trending Market Intelligence /marketintelligence/en/news-insights/trending/vpd94nkkupkr2rh1vjkqaw2 content esgSubNav
In This List

Nordic Nanovector adds board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Nordic Nanovector adds board member

Oslo-based Nordic Nanovector ASA added Rainer Boehm to its board of directors.

Boehm was previously chief commercial and medical affairs officer at Novartis Pharma in Switzerland.

Nordic Nanovector develops therapies for blood cancers.